CSF metabolomics alterations after aneurysmal subarachnoid hemorrhage: what do we know?

[1] Etminan NCH(2019)Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis JAMA Neurol 76 588-597

[2] Hackenberg K(2016)Metabolomic analysis in brain research: opportunities and challenges Front Physiol 7 183-64

[3] de Rooij NK(2006)Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods Dis Markers 22 39-173

[4] Vergouwen MDI(2020)Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach Sci Rep 10 6507-189

[5] Rinkel GJE(2008)The human cerebrospinal fluid metabolome J Chromatogr B Anal Technol Biomed Life Sci 871 164-186

[6] Algra A(2006)Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury Brain Res 1104 183-252

[7] Vasilopoulou CG(2009)Metabolomics: a global biochemical approach to the study of central nervous system diseases Neuropsychopharmacology 34 173-271

[8] Margarity M(2004)Metabolomics by numbers: acquiring and understanding global metabolite data Trends Biotechnol 22 245-293

[9] Klapa MI(2013)Metabolomics analysis for biomarker discovery: advances and challenges Curr Med Chem 20 257-641

[10] Fonteh AN(2007)Current progress in computational metabolomics Brief Bioinform 8 279-28

[1] Etminan NCH(2019)Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis JAMA Neurol 76 588-597

[2] Hackenberg K(2016)Metabolomic analysis in brain research: opportunities and challenges Front Physiol 7 183-64

[3] de Rooij NK(2006)Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods Dis Markers 22 39-173

[4] Vergouwen MDI(2020)Metabolic basis of neuronal vulnerability to ischemia; an in vivo untargeted metabolomics approach Sci Rep 10 6507-189

[5] Rinkel GJE(2008)The human cerebrospinal fluid metabolome J Chromatogr B Anal Technol Biomed Life Sci 871 164-186

[6] Algra A(2006)Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury Brain Res 1104 183-252

[7] Vasilopoulou CG(2009)Metabolomics: a global biochemical approach to the study of central nervous system diseases Neuropsychopharmacology 34 173-271

[8] Margarity M(2004)Metabolomics by numbers: acquiring and understanding global metabolite data Trends Biotechnol 22 245-293

[9] Klapa MI(2013)Metabolomics analysis for biomarker discovery: advances and challenges Curr Med Chem 20 257-641

[10] Fonteh AN(2007)Current progress in computational metabolomics Brief Bioinform 8 279-28